The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2017
Filed:
Oct. 09, 2014
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Ian Bruce, Horsham, GB;
Sylvie Chamoin, Saint Louis, FR;
Stephen Paul Collingwood, Haywards Heath, GB;
Pascal Furet, Thann, FR;
Vikki Furminger, Seaford, GB;
Diana Janus, Horsham, GB;
Sarah Lewis, Cambridge, MA (US);
Jon Christopher Loren, San Diego, CA (US);
Valentina Molteni, San Diego, CA (US);
Alex Michael Saunders, Leicester, GB;
Duncan Shaw, Sharon, MA (US);
Lilya Sviridenko, Shalford, GB;
Christopher Thomson, Belmont, MA (US);
Ryan West, Horsham, GB;
Vince Yeh, San Diego, CA (US);
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/444 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/444 (2013.01); A61K 31/4545 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01);
Abstract
Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity. wherein A is and R, R, R, R, R, R, Rand X are as defined herein.